Agreement regarding overcoming hypertension in the Asian Hypertension Society Network 2022

Hoshide, Satoshi and Yamamoto, Koichi and Katsurada, Kenichi and Yano, Yuichiro and Nishiyama, Akira and Wang, Ji-Guang and Narasingan, S N and Verma, Narsingh and Erwinanto, Erwinanto and Turana, Yuda and Ihm, Sang Hyun and Park, Sungha and Hanafi, Nik Sherina and Chia, Yook Chin * and Unurjargal, Tsolmon and Siddique, Saulat and Ona, Deborah Ignacia D and Venketasubramanian, Narayanaswamy and Teo, Boon Wee and Constantine, Godwin and Kao, Hsien-Li and Hung, Chi-Sheng and Sukonthasarn, Apichard and Kunanon, Sirisawat and Minh, Huynh Van and Kario, Kazuomi and Node, Koichi and Itoh, Hiroshi and Rakugi, Hiromi (2023) Agreement regarding overcoming hypertension in the Asian Hypertension Society Network 2022. Hypertension Research, 46 (1). pp. 3-8. ISSN 1348-4214

Preview

Text Chia Yook Chin_Agreement regarding overcoming hypertension in the Asian.pdf - Published Version Available under License Creative Commons Attribution. Download (376kB) | Preview

Abstract

The global burden of hypertension has already been acknowledged. The reduction in blood pressure (BP) significantly reduces cardiovascular morbidity and mortality. Half of the world’s population is concentrated in Asia, and this proportion is expected to continue to increase. As the population ages, the number of people suffering from hypertension is also expected to increase. It is critical to address hypertension in Asia. To do so, it is necessary to establish a common direction for the control of hypertension within the Asian region. Within Asia, religions and cultures differ, and economic development differs from region to region. However, despite this diversity, things will not progress efficiently or in a certain direction unless certain rules are in place. After convening the International Society of Hypertension (ISH) 2022 in Kyoto, Japan, we would like to present the direction agreed upon by the regional hypertension societies toward the goal of addressing hypertension in Asia. In particular, we focused on three points: target BP, sodium restriction, and out-of-office BP measurement.

Actions (login required)

View Item